Specimen handling and preparation methods for cytologic material
As for the handling of TBNA specimens, in those cases in which a histologic core of tissue has been obtained, it is removed gently from the needle's tip and placed in formalin solution before being sent for staining and pathologic analysis [1, 12] . Cytologic material can be managed in two different ways: 1) "smear" ("direct") technique: the aspirate's content material is collected on clean glass slides that are quickly air-or alcohol-fixed before being sent for staining and pathologic analysis. 2) "flush technique": the aspirate's content is deposited in 2 mL 95% alcohol which undergoes cytocentrifugation, cell pellet resuspension and staining [1] . Diacon and Coll . recently compared the two preparation methods and concluded that the "direct" technique is associated with a higher yield than the "flush" technique even after stratification for anatomical site and tumour type [13] .
It should be noted, however, that alternative or adjunctive preparation methods can be required based on clinicoradiological data or pathologist's preference. In patients with suspected mediastinal infection (especially mycobacterial infection) or lymphoma, the aspirate's content should also be deposited in saline solution for culture or flow cytometric analysis, respectively.
Recommendation
• Cytologic material obtained with TBNA should be prepared with the smear (direct) technique (Grade B).
Indications

a) Mediastinal lesions
Any lesion involving the middle mediastinum and in close contact with the airway wall is potentially suitable for TBNA sampling.
Bronchogenic carcinoma
TBNA, mainly if performed at the time of initial diagnostic bronchoscopy, can offer the unique opportunity to prevent patients with lymph node extension of primary tumour from being submitted to unnecessary surgical mediastinal exploration. In those cases in which TBNA is performed at the time of initial diagnostic bronchoscopy along with other sampling bronchoscopic procedures aimed at typing the primary tumour, TBNA may be the only positive test in a considerable percentage of cases.
After two decades of use, strengths and limits of TBNA in the mediastinal staging of NSCLC are quite well known and have been thoroughly described in two recent extensive literature reviews. In 2007, Detterbeck et al. performed a systematic review on 17 studies where TBNA was used to stage the mediastinum of 1339 patients with NSCLC [14] . The overall sensitivity and specificity were 78% and 99%, respectively. The main limit of TB-NA was its high false negative rate (approximately 30%), which suggests that a negative transbronchial aspirate result must not negate further evaluation with more invasive sampling techniques mainly if the clinical-radiological suspect of lymph node metastasis is high. A more recent meta-analysis on the results of TBNA in the mediastinal staging of lung cancer selected, based on rigorous criteria, 13 studies out of 525 initially taken into account [15] . The analysis basically confirmed the very high specificity of the method, but also clearly demonstrated that its yield as well as its positive predictive value largely depend on the prevalence of lymph node metastasis in the population being studied. In particular, the diagnostic yield of TBNA proved high in studies with high prevalence of N2-N3 involvement, and the general implication was that the mediastinal nodes were markedly enlarged in these study populations. On the contrary, TBNA yield was much lower than previously thought in populations with low prevalence of lymph node metastasis. This data suggests that the primary role for TB-NA in the mediastinal staging of NSCLC should be that of confirming a neoplastic lymph node involvement which looks likely based on the imaging techniques results, by virtue of its high specificity and sensitivity in this specific setting.
Several studies have evaluated a number of factors to explain the differences seen among the reported diagnostic yields of the procedure in the mediastinal staging of NSCLC, and identified several predictors of a positive TBNA aspirate such as: high prevalence of lymph node metastasis in the study population [14, 15] , increasing lymph node size [8, 16] , right paratracheal and subcarinal locations [8, 12, 16] , use of a histology needle [17] , increasing number of needle passes up to 7 [18] , experience of the operator [19] [20] , and small-cell carcinoma histologic type [8, 16, [21] [22] [23] [24] . Rapid on-site cytopathologic examination (ROSE) was initially thought to increase both the percentage of adequate samples and diagnostic yield of TBNA [25] [26] [27] , but more recent data suggests that the main utility of ROSE in the setting of mediastinal TBNA is its capacity to defer additional biopsy and reduce the complication rate of bronchoscopy without compromising its diagnostic success [28] [29] .
Recommendation
• TBNA or EBUS-TBNA should be performed in every patient with radiological suspicion of lung cancer and mediastinal involvement, provided that the mediastinal staging is crucial for the therapeutic choice (Grade B).
Hylar and/or mediastinal lymphadenopathy
Several studies investigated the usefulness of TBNA in an unselected group of patients with hylar and or mediastinal lymphadenopathy. Such a study population is likely to include patients with several different diseases (neoplastic, infectious, inflammatory), and it allows to evaluate the performance of TBNA in patients who are selected almost exclusively based on their imaging findings. The vast majority of these studies concluded that TBNA is safe and effective in this setting and almost uniformly reported a diagnostic yield superior to 60% [30] [31] [32] [33] .
Recommendation
• TBNA or EBUS-TBNA should be the initial diagnostic procedure in patients with hylar and/or mediastinal lymphadenopathy, provided that the enlarged nodes are in close contact with the airway wall (Grade B).
Granulomatous disorders
TBNA has been used with satisfactory results in patients with clinical suspicion of sarcoidosis or mycobacterial infection.
Conventional TBNA has been shown to increase the diagnostic yield of bronchoscopy in the setting of sarcoidosis when performed along with the other sampling procedures (bronchoaveolar lavage, bronchial and transbronchial biopsy) [34] [35] [36] [37] [38] . The diagnostic yield of TBNA was particularly high (>70%) in stage I, whereas less satisfactory and widely variable results have been reported for the method in stage II [34] [35] [36] [37] [38] . More recently, a uniformly higher diagnostic yield has been obtained, both in stage I and in stage II, with ultrasound-guided TBNA [39, 40] , and this superiority has been confirmed in a randomised trail comparing EBUS-guided versus conventional TBNA [41] .
In the last decade, some groups of investigators reported their experience with the use of TBNA and EBUS-TBNA in the diagnosis of mediastinal/hilar lymph node involvement due to mycobacterial disease both in the setting of immunocompetent and immunocompromised patients [42] [43] [44] .
Bilaceroglu et al. obtained very good results by using a 19-gauge histology needle for diagnosing isolated mediastinal/hilar tuberculosis in a large series of immunocompetent patients [42] . Sensitivity and specificity of the method were 83% and 100% respectively and TBNA was the only means of diagnosis in 68% of patients. Positive culture on TBNA specimens was obtained in 27% of cases. As already observed in the diagnosis and staging of lung cancer, TBNA procedures performed in the right paratracheal and subcarinal areas yielded the best results (91% and 100%, respectively), and the main limit of the method was the unsatisfactory negative predictive value (38%). Hassan et al. obtained excellent results (sensitivity 95%, accuracy 79%) by using EBUS-TBNA in a small series (24 patients) of patients with isolated thoracic tuberculous adenopathy [43] . The only possible problem limiting the generalisation of the results of both these studies is the fact that the authors included a cohort of patients with a high pretest probability of tuberculosis, selected based on strong tuberculin skin test, high prevalence of symptoms, and originating from a country with a high prevalence of tuberculosis [42, 43] .
Harkin et al. reported their experience with TBNA in the diagnosis of mediastinal/hilar adenopathy in patients infected with the acquired immunodeficiency virus [44] . By using a 19-gauge histology needle, the authors were able to diagnose 80% of patients with tuberculosis and 100% of patients with mediastinal lymph node disease due to mycobacteria other than tuberculosis. TBNA was the only means of diagnosis in 48% of cases. Curiously, a positive culture of TBNA specimens was obtained in 61% of cases, a much higher percentage than that usually observed in immunocompetent patients in the same setting [44] . 
b) Central lesions
Lung cancer may present in the central airway with four different patterns of involvement: 1) exophytic mass lesion; 2) submucosal infiltration; 3) peribronchial pattern with extrinsic compression; 4) peribronchial pattern without signs of extrinsic compression.
Importantly, exophytic lesions cause significant mucosal abnormality, whereas submucosal infiltration and, especially, peribronchial lesions may leave the mucosal surface almost intact. Dasgupta and coll. prospectively investigated the diagnostic yield of standard bronchoscopic sampling procedures (bronchial washing, bronchial brushing, endobronchial biopsy) with that obtained with standard procedures plus TBNA [45] . Of the 55 patients with central lung cancer included in the study, 32 had an exophytic mass whereas the remaining 23 patients had either a submucosal pattern or extrinsic compression [45] . The highest yield from any individual bronchoscopic procedure was obtained by TBNA. The combined use of standard bronchoscopic sampling procedures plus TBNA offered a statistically significant advantage as compared to standard procedures alone in patents with submucosal pattern or extrinsic compression (96% vs 65%, p=0.016). The ability of TBNA to penetrate either the submucosal layer or the bronchial wall into the tumour mass is the likely explanation for the above results. In patients with exophytic mass lesion, the combination of standard procedures plus TBNA was also associated with an increase of the diagnostic yield, yet not reaching statistical significance. The extra value of TBNA in exophytic lesions might be explained by its ability to bypass surface necrosis and sample from deep inside the lesion. Moreover, in the specific setting of small cell lung cancer crush artefacts produced during forceps biopsy may be responsible for a non-diagnostic result [45] . The results obtained by Dasgupta et al. have been confirmed in several other studies with similar design [46] [47] [48] .
More recently, EBUS-TBNA has shown its ability to localise and sample central malignant lesions growing with a peribronchial pattern, yet not compressing the airways [49, 50] . Tournoy et al. performed EBUS-TBNA in 60 patients with peribronchial central lesion, most of whom had had a prior, non diagnostic bronchoscopy. They obtained an 82% sensitivity and could cancel transthoracic needle aspiration in 47% of patients and surgery in 30% of patients [49] . These studies suggest that EBUS-TBNA should be the first-step technique in the diagnostic approach to peribronchial central lung lesions not compressing the airways.
Recommendations
• In the diagnostic approach to a "central" malignant lesion there is indication to TBNA use when the pattern of airway involvement is either submucosal or peribronchial (extrinsic compression) (Grade B).
• In the diagnostic approach to a "central" malignant lesion there is indication to the use of EBUS-TBNA when the pattern of airway involvement is peribronchial, especially if there is no sign of extrinsic compression (Grade B).
c) Peripheral lesions
Bronchoscopy in patients with peripheral lung lesions may have both staging and diagnostic purposes. The inspection of the airways allows, in fact, to complete the definition of the "T descriptor" of the TNM staging system, and to rule out the existence of synchronous lesions. As for the diagnosis, the yield of standard bronchoscopic sampling procedures (bronchial washing, bronchial brushing, transbronchial biopsy) in this setting depends on several variables such as size of the lesion, presence/absence of the bronchus sign, use of imaging techniques to guide the sampling [49] .
In a recent, systematic literature review, Schreiber analysed the 5 studies (793 patients included) in which TBNA had been performed, under fluoroscopy, along with other bronchoscopic sampling procedures, and he demonstrated that the method was associated with a higher yield (67%) than bronchoalveolar lavage (42%), bronchial brushing (52%), and transbronchial biopsy (46%) [51] . Katis et al. prospectively investigated the diagnostic yield of standard bronchoscopic sampling procedures (bronchial washing, transbronchial biopsy) with that obtained with standard procedures plus TBNA [52] . The yield of TBNA under fluoroscopic guidance was superior to that of bronchial washing (62% vs 24%, p<0.005), bronchial brushing (62% vs 27%, p<0.005), and transbronchial biopsy (62% vs 38%, p<0.005). The combined use of standard bronchoscopic sampling procedures and TBNA offered a statistically significant advantage as compared to standard procedures alone (70% vs 46%, p<0.05).
Interestingly, similar results have been recently reported by Chao et al., who evaluated for the first time, the added value of TBNA guided by endobronchial ultrasound in patients with peripheral pulmonary lesions. The authors, in fact, demonstrated that the sensitivity of TBNA (72%) was higher than that of both transbronchial lung biopsy (50%, p=0.004) and bronchial washing (13.5%, p<0.001).
In conclusion, there is strong evidence in the literature that TBNA improves the diagnostic yield of bronchoscopy in patients with peripheral lesions, whatever the imaging guide [53] [54] [55] [56] . 
